TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15136071

Group type: EXPERIMENTAL
Intervention: Pr‐LPL mass
Number of subjects: 81
Study: 11568049

Group type: EXPERIMENTAL
Intervention: Hypoxia (17% FIO2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypercarbia (2.7% FICO2)
Number of subjects: 10
Study: 9760627

Group type: EXPERIMENTAL
Intervention: Revised form of the answer sheet for the Speech‐Sounds Perception Test (error types randomized)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard form of the answer sheet for the Speech‐Sounds Perception Test
Number of subjects: 40
Study: 7918132

Group type: EXPERIMENTAL
Intervention: Isradipine 10 mg bid
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 2830189

Group type: EXPERIMENTAL
Intervention: Enalapril, 20 mg daily for 6 weeks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diltiazem, 120 mg daily for 6 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nifedipine, 10 mg p.o. during washout phase
Number of subjects: 16

Group type: COMPARATOR
Intervention: Enalaprilat, 5 mg i.v. during washout phase
Number of subjects: 16
Study: 30963177

Group type: EXPERIMENTAL
Intervention: Nutrition (child nutrition counseling plus lipid-based nutrient supplements)
Number of subjects: 1512

Group type: EXPERIMENTAL
Intervention: Nutrition plus WSH (N+WSH)
Number of subjects: 1512

Group type: EXPERIMENTAL
Intervention: All interventions (WSH, Nutrition, N+WSH)
Number of subjects: 1512

Group type: EXPERIMENTAL
Intervention: WSH
Number of subjects: 1512

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1512
Study: 31165374

Group type: EXPERIMENTAL
Intervention: Patient-family agenda setting intervention
Number of subjects: 132

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 132
Study: 27832331

Group type: EXPERIMENTAL
Intervention: Nasogastric tube (NG group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No nasogastric tube (NNG group)
Number of subjects: 60
Study: 26421634

Group type: EXPERIMENTAL
Intervention: Active placebo treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Inactive placebo treatment
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 35
Study: 23491407

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 12
Study: 20153492

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion (0.05 μg/[kg min])
Number of subjects: 10

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 10
Study: 19187819

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral treatment (GCBT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Minimum contact comparison group (MCC)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: GCBT
Number of subjects: 33
Study: 16717173

Group type: EXPERIMENTAL
Intervention: Computer-based health risk assessment with a prompt for the health care provider
Number of subjects: 1281

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1281
Study: 15251401

Group type: EXPERIMENTAL
Intervention: Oral chloramphenicol (500 mg every six hours for five days)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study: 11312316

Group type: EXPERIMENTAL
Intervention: Early-blind subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sighted subjects
Number of subjects: 0
Study: 9220217

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 7660719

Group type: EXPERIMENTAL
Intervention: GnRH-A
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pill-combined and GnRH
Number of subjects: 25
Study: 3307886

Group type: EXPERIMENTAL
Intervention: Evening primrose oil (EPO)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31974572

Group type: EXPERIMENTAL
Intervention: Improved infant and young child feeding (IYCF)
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: HIV-exposed uninfected (CHEU)
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: HIV-exposed children in non-IYCF arms
Number of subjects: 738
Study: 29266093

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training with blood flow restriction (LI-RT + BFRT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (HI-RT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low-intensity resistance training (LI-RT)
Number of subjects: 48
Study: 28556962

Group type: EXPERIMENTAL
Intervention: 12-h IV retosiban followed by a single dose of oral placebo (R-P)
Number of subjects: 29

Group type: COMPARATOR
Intervention: 12-h IV placebo followed by single-dose oral retosiban (P-R)
Number of subjects: 29
Study: 25074756

Group type: EXPERIMENTAL
Intervention: Topical brimonidine tartrate (BT) 0.5% gel, applied once daily for 4 weeks
Number of subjects: 553

Group type: COMPARATOR
Intervention: Vehicle gel, applied once daily for 4 weeks
Number of subjects: 553
Study: 23345118

Group type: EXPERIMENTAL
Intervention: Forewarned participants about the nature of the DRM task prior to encoding (Exp. 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Participants not forewarned about the nature of the DRM task (Exp. 2)
Number of subjects: 0
Study: 21205412

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17919545

Group type: EXPERIMENTAL
Intervention: Garenoxacin 400 mg QD for 5 days
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Garenoxacin 400 mg QD for 10 days
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Garenoxacin 400 mg QD for 5 or 10 days
Number of subjects: 546
Study: 15688694

Group type: EXPERIMENTAL
Intervention: Kangfu Xiaozheng Tablet
Number of subjects: 120

Group type: COMPARATOR
Intervention: Guizhi Fuling Pill
Number of subjects: 120
Study: 11160062

Group type: EXPERIMENTAL
Intervention: Ketoprofen (300 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ketoprofen and Placebo
Number of subjects: 21
Study: 9708579

Group type: EXPERIMENTAL
Intervention: Statistical process control (SPC) methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Run charts, control charts, and regression models
Number of subjects: 0
Study: 8270982

Group type: EXPERIMENTAL
Intervention: DAVTH reinduction after relapse
Number of subjects: 106

Group type: COMPARATOR
Intervention: Observation after induction CR
Number of subjects: 106
Study: 2643965

Group type: EXPERIMENTAL
Intervention: Analgesics and a standard circumferential rib belt (Zimmer Universal Rib Belt)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Oral analgesics alone
Number of subjects: 25
Study: 31564599

Group type: EXPERIMENTAL
Intervention: Tobacco prevention presentation
Number of subjects: 2257

Group type: COMPARATOR
Intervention: Control condition (no presentation)
Number of subjects: 2257
Study: 29753538

Group type: EXPERIMENTAL
Intervention: Oral anticoagulant (OAC) indication
Number of subjects: 969
Study: 26297321

Group type: EXPERIMENTAL
Intervention: Generalist Approach - Brief Intervention (BI) delivered by primary care provider
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Specialist Approach - Brief Intervention (BI) delivered by behavioral health counselors
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Integration of HIV risk screening within SBIRT model
Number of subjects: 7

Group type: COMPARATOR
Intervention: Implementation Strategies
Number of subjects: 7
Study: 24732127

Group type: EXPERIMENTAL
Intervention: Phenolization with curettage
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Phenolization alone
Number of subjects: 90

Group type: COMPARATOR
Intervention: Curettage
Number of subjects: 90

Group type: COMPARATOR
Intervention: Phenolization
Number of subjects: 90
Study: 23089925

Group type: EXPERIMENTAL
Intervention: Statins treatment for 2 weeks
Number of subjects: 720

Group type: COMPARATOR
Intervention: Control groups (normal and high-risk)
Number of subjects: 720
Study: 20166405

Group type: EXPERIMENTAL
Intervention: HB (at-home bleaching with 10% carbamide peroxide for two weeks)
Number of subjects: 90

Group type: COMPARATOR
Intervention: OBL (in-office bleaching with 35% hydrogen peroxide, two sessions, two-week intervals, with light irradiation)
Number of subjects: 90

Group type: COMPARATOR
Intervention: OB (in-office bleaching without light irradiation)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination (one session plus HB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: HE (home bleaching)
Number of subjects: 90

Group type: COMPARATOR
Intervention: OBL and OB
Number of subjects: 90
Study: 18398079

Group type: EXPERIMENTAL
Intervention: TACE-RFA
Number of subjects: 291

Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 291

Group type: COMPARATOR
Intervention: RFA alone
Number of subjects: 291
Study: 16047223

Group type: EXPERIMENTAL
Intervention: Levamisole 2.5 mg/kg on alternate days
Number of subjects: 40

Group type: COMPARATOR
Intervention: I.V. cyclophosphamide 500 mg/m2/month for six months
Number of subjects: 40
Study: 21067347

Group type: EXPERIMENTAL
Intervention: Val 160/HCTZ 12.5
Number of subjects: 2002

Group type: EXPERIMENTAL
Intervention: Val 160/HCTZ 25
Number of subjects: 2002

Group type: COMPARATOR
Intervention: Val 160
Number of subjects: 2002
Study: 10820175

Group type: COMPARATOR
Intervention: 15 mg/d folic acid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 30 mg/d folic acid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 60 mg/d folic acid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 60 mg/d folic acid in MTHFR 677TT genotype patients
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 30 or 60 mg/d folic acid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: MTHFR 677TT genotype
Number of subjects: 150
Study: 8785167

Group type: EXPERIMENTAL
Intervention: Topical tretinoin
Number of subjects: 27
Study: 1514338

Group type: EXPERIMENTAL
Intervention: Intermittent wound infiltration with bupivacaine and continuous coeliac plexus blockade (total 862.5 mg over 12 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intermittent wound infiltration with bupivacaine and continuous coeliac plexus blockade
Number of subjects: 20
Study: 6341873

Group type: EXPERIMENTAL
Intervention: Chronic oral taurine administration
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 29943100

Group type: EXPERIMENTAL
Intervention: Sub-tenon steroid injection (Triamcinolone acetonide) plus anti-VEGF injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anti-VEGF injection only
Number of subjects: 0
Study: 28334499

Group type: EXPERIMENTAL
Intervention: Dorsal Root Ganglion (DRG) stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dorsal Column (DC) stimulation
Number of subjects: 12
Study: 27112245

Group type: EXPERIMENTAL
Intervention: Simethicone addition group (400 mg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Water addition group (1 L)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Simethicone addition group
Number of subjects: 90

Group type: COMPARATOR
Intervention: PEGA group
Number of subjects: 90
Study: 25246693

Group type: EXPERIMENTAL
Intervention: Artesunate‐amodiaquine
Number of subjects: 747

Group type: COMPARATOR
Intervention: Artemether‐lumefantrine
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 747
Study: 22541389

Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 695

Group type: COMPARATOR
Intervention: Conservative management (watchful waiting)
Number of subjects: 695
Study: 19053054

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (Botox)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: NT201 (Xeomin)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Botulinum toxin type A (Botox) and NT201 (Xeomin)
Number of subjects: 300
Study: 17669862

Group type: EXPERIMENTAL
Intervention: Edwards Perimount Magna (EPM) valve
Number of subjects: 86

Group type: COMPARATOR
Intervention: Medtronic Mosaic (MM) bioprosthesis
Number of subjects: 86
Study: 16294803

Group type: EXPERIMENTAL
Intervention: SimplyThick
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Thick-It
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Natural thickeners
Number of subjects: 43

Group type: COMPARATOR
Intervention: Commercial thickeners
Number of subjects: 43
Study: 11980869

Group type: EXPERIMENTAL
Intervention: Granulocyte colony stimulating factor (G-CSF, 300 microg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10636597

Group type: EXPERIMENTAL
Intervention: Pacifier sucking
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Digit sucking
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bed sharing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Non-routine location
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking
Number of subjects: 10
Study: 7552468

Group type: EXPERIMENTAL
Intervention: Deep acupuncture
Number of subjects: 20

Group type: COMPARATOR
Intervention: Superficial acupuncture
Number of subjects: 20
Study: 1773316

Group type: EXPERIMENTAL
Intervention: Division of lateral ligaments during rectopexy
Number of subjects: 26

Group type: COMPARATOR
Intervention: Preservation of lateral ligaments during rectopexy
Number of subjects: 26
Study: 6982270

Group type: EXPERIMENTAL
Intervention: Cold cardioplegia with topical deep hypothermia using Bretschneider solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intermittent aortic cross clamping at 30 degrees C
Number of subjects: 20
Study: 31810378

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal Sleep
Number of subjects: 20
Study: 31192515

Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection into the right masseter muscle
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isotonic saline (IS) injection into the right masseter muscle
Number of subjects: 42
Study: 27341122

Group type: EXPERIMENTAL
Intervention: Oral Misoprostol
Number of subjects: 502

Group type: COMPARATOR
Intervention: Foley Catheter
Number of subjects: 502
Study: 26950019

Group type: EXPERIMENTAL
Intervention: Carbamazepine, Lithium Carbonate, or Valproic Acid (monotherapy)
Number of subjects: 68
Study: 23102577

Group type: EXPERIMENTAL
Intervention: External cephalic version (ECV)
Number of subjects: 212
Study: 25426786

Group type: EXPERIMENTAL
Intervention: Topical + intrasulcular hyaluronan gel
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Topical hyaluronan gel
Number of subjects: 28

Group type: COMPARATOR
Intervention: Scaling
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Scaling + topical hyaluronan gel
Number of subjects: 28
Study: 19016469

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 1094

Group type: COMPARATOR
Intervention: Ticlopidine
Number of subjects: 1094
Study: 16928941

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced sonography
Number of subjects: 186

Group type: COMPARATOR
Intervention: Unenhanced sonography
Number of subjects: 186
Study: 14624399

Group type: EXPERIMENTAL
Intervention: Combined training group (CT) - weight training plus aerobic training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Aerobic training group (AT) - aerobic training only
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CG) - no exercise
Number of subjects: 36
Study: 10625096

Group type: EXPERIMENTAL
Intervention: Phosphate supplementation of human milk
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Fortified supplementation with protein, calcium, and phosphorus
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Preterm formula
Number of subjects: 127

Group type: COMPARATOR
Intervention: Own mother's milk only
Number of subjects: 127
Study: 9206860

Group type: EXPERIMENTAL
Intervention: Intermittent prophylaxis (diazepam at fever)
Number of subjects: 289

Group type: COMPARATOR
Intervention: No prophylaxis (diazepam at seizures)
Number of subjects: 289
Study: 1304644

Group type: EXPERIMENTAL
Intervention: Miniwright peak flow meter
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vitalograph peak flow meter
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Assess peak flow meter
Number of subjects: 100
Study: 3519550

Group type: EXPERIMENTAL
Intervention: 60Co radiation
Number of subjects: 1115

Group type: COMPARATOR
Intervention: Conventional roentgen unit
Number of subjects: 1115
Study: 30232551

Group type: EXPERIMENTAL
Intervention: Continuous intraoperative electromyographic neuromonitoring
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (no continuous intraoperative electromyographic neuromonitoring)
Number of subjects: 106
Study: 26545174

Group type: EXPERIMENTAL
Intervention: Multiband mucosectomy (MBM)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cap-assisted endoscopic resection
Number of subjects: 84
Study: 25366542

Group type: EXPERIMENTAL
Intervention: Health promotion intervention delivered quarterly over 15 months, involving educational activities, peer discussion, a DVD, and written materials
Number of subjects: 542

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 542
Study: 21766226

Group type: EXPERIMENTAL
Intervention: Incremental arm exercise (10 W min(‐1))
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Incremental leg exercise (25 W min(‐1))
Number of subjects: 10

Group type: COMPARATOR
Intervention: Reference test (RT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: AL (Incremental ramp exercise)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: LL (Incremental ramp exercise)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: LL
Number of subjects: 10
Study: 21214094

Group type: EXPERIMENTAL
Intervention: Beating-heart technique with retrograde coronary sinus perfusion
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional aortic valve replacement
Number of subjects: 35
Study: 18386255

Group type: EXPERIMENTAL
Intervention: 100 mg Pycnogenol daily (oral capsules)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 18077797

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 15218810

Group type: EXPERIMENTAL
Intervention: Intramuscular interferon-beta Ia
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11719893

Group type: EXPERIMENTAL
Intervention: H-high (hypoxia, high intensity)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: N-high (normoxia, high intensity)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: H-low (hypoxia, low intensity)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: N-low (normoxia, low intensity)
Number of subjects: 33
Study: 9424007

Group type: EXPERIMENTAL
Intervention: Carbogen
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Nicotinamide (80 mg/kg/day)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ARCON (Accelerated Radiotherapy, CarbOgen, Nicotinamide)
Number of subjects: 35

Group type: COMPARATOR
Intervention: CHART (Control)
Number of subjects: 35
Study: 8479489

Group type: EXPERIMENTAL
Intervention: Atovaquone (750 mg, orally, three times daily for 21 days)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Trimethoprim (320 mg) plus sulfamethoxazole (1600 mg, orally, three times daily for 21 days)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Atovaquone
Number of subjects: 322

Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 322
Study: 3565410

Group type: EXPERIMENTAL
Intervention: Clinical pharmacy services provided by two pharmacists to a randomly selected cluster of family practice physicians for six months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group of family practice physicians who did not receive clinical pharmacy services.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both intervention and control groups.
Number of subjects: 0
Study: 30663775

Group type: EXPERIMENTAL
Intervention: On-line intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 60
Study: 30402136

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control Group 1 (CTR 1)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control Group 2 (CTR 2)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control Group 3 (CTR 3)
Number of subjects: 69
Study: 26878318

Group type: EXPERIMENTAL
Intervention: Boiled and mashed potatoes (BMP)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Fried French fries (FFF)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Rice, pasta, baked French fries (BFF)
Number of subjects: 34
Study: 25392505

Group type: EXPERIMENTAL
Intervention: Olfactory aversive conditioning during stage 2 sleep
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Olfactory aversive conditioning during REM sleep
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control sleep experiments (aversive odors alone and effects of cigarette odors and aversive odors without pairing)
Number of subjects: 66
Study: 22949277

Group type: EXPERIMENTAL
Intervention: Intervention designed to improve the quality of life of spousal caregivers
Number of subjects: 0
Study: 21129179

Group type: EXPERIMENTAL
Intervention: Patient-led teaching module incorporated into the mandatory training of junior doctors on patient safety.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attitudes to Patient Safety Questionnaire (APSQ) as the primary quantitative outcome measure.
Number of subjects: 0
Study: 17980044

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture (TCA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham acupuncture (Sham)
Number of subjects: 36
Study: 15800019

Group type: EXPERIMENTAL
Intervention: Standard-dose reteplase
Number of subjects: 11420

Group type: EXPERIMENTAL
Intervention: Half-dose reteplase plus abciximab
Number of subjects: 11420

Group type: COMPARATOR
Intervention: Both groups (standard-dose reteplase and half-dose reteplase plus abciximab)
Number of subjects: 11420
Study: 12047207

Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chair sitting position
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Head down tilt position
Number of subjects: 36